Clearbridge Investments LLC Sells 469,676 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ultragenyx Pharmaceutical's (RARE) Overweight Rating Reaffirmed at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ultragenyx Pharmaceutical Inc (RARE) revealed Loss for fourth quarter that decreased from the same period last year and beat the Street estimates. The company's earnings came in at -$123.
On the last day of 2023, PRIMECAP Management (Trades, Portfolio) made a notable addition to its investment portfolio by acquiring additional shares in Biomarin Pharmaceutical Inc (NASDAQ:BMRN). This move increased PRIMECAP Management (Trades, Portfolio)'s total holdings in the company to 18,414,374 shares, solidifying its position with a 1.5% portfolio weight and a 9.78% stake in Biomarin Pharmaceutical.